ADVERTISEMENT
ADVERTISEMENT
Vas Narasimhan appointed to Anthropic board
Narasimhan, with his roots tracing back to Tamil Nadu, India, is currently the CEO of Swiss multinational pharmaceutical corporation Novartis.
-
1759953093.png)
Staff Reporter - Wed, 15, Apr 2026
- 03:45 EDT
- 18
Vasant Narasimhan, CEO, Novartis / Wikimedia commons
Indian American tech CEO Vas Narasimhan has been appointed to the board of directors of San Francisco, California-based AI company Anthropic.
Narasimhan, who currently serves as the CEO of Swiss multinational pharmaceutical corporation Novartis, is a physician-scientist and has been appointed by the Anthropic Long-Term Benefit Trust.
He is a physician-scientist and shares Anthropic’s belief that “health care and life sciences are among the areas where AI has the greatest potential to improve the quality of human life,” the company noted in a statement.
“Vas brings something rare to our board. He’s overseen the development and approval of more than 35 novel medicines for the benefit of patients around the world in one of the most regulated industries,” said Daniela Amodei, co-founder and president of Anthropic.
ALSO READ: India’s SEBI chief engages with Silicon Valley investors
Amodei continued, “Getting powerful new technology to people safely and at scale is what we think about every day at Anthropic. Vas has been doing exactly that for years, and I’m grateful he’s joining us.”
The trust that appointed Narasimhan is an independent body whose members have no financial stake in Anthropic, and it exists to keep the company’s governance aligned in a responsible balance between financial success and the company’s public benefit mission of developing AI for the long-term benefit of humanity.
With Narasimhan’s appointment, trust-appointed directors now make up a majority of the board. Narasimhan joins Dario Amodei, Daniela Amodei, Yasmin Razavi, Jay Kreps, Reed Hastings and Chris Liddell on the board of directors.
Talking about his new role, Narasimhan said, “Working across medicine, innovation and global health has shown me the transformative potential of technology when deployed responsibly. In health care, AI is accelerating solutions to some of the hardest scientific challenges, from deepening our understanding of disease biology to designing better medicines.”
He continued, “Anthropic is setting the standard for how AI should be developed to benefit humanity, and I’m honored to join the board and contribute to its mission.”
Vas Narasimhan has previously worked on HIV/AIDS, malaria and tuberculosis programs in India, Africa and South America. He continues to advocate for global health and improved access to medicines.
An alumnus of the University of Chicago and Harvard Medical School, he is also an elected member of the U.S. National Academy of Medicine and a member of the Council on Foreign Relations.
Read more stories on NewIndiaAbroad
Related
ADVERTISEMENT
ADVERTISEMENT
E Paper
Video
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login